Henry Schein (HSIC) Stock Price
Henry Schein Price
Henry Schein (HSIC) Stock | ISIN US8064071025 | WKN 897961. The current Henry Schein stock price is 78.05 USD (2026). Revenue is 13.99 B USD. Net income is 622.68 M USD. The P/E ratio is 15.26. Market capitalization is 8.95 B USD. Henry Schein operates in the Health sector.
Henry Schein stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of Henry Schein over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Henry Schein stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Henry Schein's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | Henry Schein Price |
|---|
Henry Schein Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
Henry Schein Income Statement, Balance Sheet, Cash Flow Statement
| REVENUE (M USD) |
|---|
| REVENUE GROWTH (%) |
| GROSS MARGIN (%) |
| GROSS INCOME (M USD) |
| NET INCOME (M USD) |
| NET INCOME GROWTH (%) |
| SHARES (M) |
| DOCUMENTS |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales Henry Schein generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Henry Schein retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Henry Schein's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares Henry Schein has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Henry Schein's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Henry Schein stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
Henry Schein Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
Henry Schein business model & stock analysis
Henry Schein SWOT Analysis
Strengths
Henry Schein Inc has a diverse and extensive product portfolio, offering a wide range of medical, dental, and veterinary supplies. This allows the company to cater to the needs of various healthcare professionals and positions itself as a one-stop solution provider in the industry.
The company has a well-established and efficient distribution network, enabling it to efficiently deliver products to customers across geographies. This ensures timely availability of supplies and enhances customer satisfaction.
Weaknesses
Henry Schein Inc relies on a network of suppliers for its product offerings. Any disruption in the supply chain or the inability to secure necessary supplies could negatively impact the company's operations and customer satisfaction.
The healthcare industry is highly competitive, with numerous players competing for market share. Henry Schein Inc faces competition from both large multinational corporations and smaller regional distributors, making it essential for the company to continuously innovate and differentiate itself to maintain its market position.
Opportunities
With the growing emphasis on healthcare worldwide, there is an opportunity for Henry Schein Inc to expand its product offerings and capture a larger market share. The rising demand for healthcare supplies and equipment presents potential for the company to explore new markets and tap into emerging economies.
Technological advancements in the healthcare industry open doors for innovation and improved solutions. Henry Schein Inc can leverage these technological advancements to enhance its product portfolio, streamline operations, and provide value-added services to customers.
Threats
Compliance with complex healthcare regulations across different jurisdictions can pose challenges for Henry Schein Inc. Regulatory changes or non-compliance can impact the company's operations and require significant investments to stay updated and meet the necessary standards.
Economic fluctuations and uncertainties can affect the demand for healthcare products and services. Henry Schein Inc needs to monitor and adapt to changes in the economic environment to mitigate the potential impact on its business.
Henry Schein Eulerpool Fair Value
Henry Schein historical P/E ratio, EBIT multiple, and P/S ratio
Henry Schein annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
Henry Schein shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
Henry Schein Earnings Estimates
Henry Schein Earnings Estimates
| Date | EPS estimate | Revenue Estimate | Quarterly report |
|---|---|---|---|
| 5/12/2026 | 1.24USD | 3.41 BUSD | 2026 Q1 |
| 5/4/2026 | 1.24USD | 3.41 BUSD | 2026 Q1 |
| 2/24/2026 | 1.33USD | 3.41 BUSD | 2025 Q4 |
| 11/11/2024 | 1.2USD | 3.31 BUSD | 2024 Q3 |
| 5/7/2024 | 1.15USD | 3.21 BUSD | 2024 Q1 |
| 2/14/2024 | 0.73USD | 3.13 BUSD | 2023 Q4 |
| 7/31/2023 | 1.23USD | 3.13 BUSD | 2023 Q2 |
| 5/1/2023 | 1.27USD | 3.19 BUSD | 2023 Q1 |
| 2/13/2023 | 1.24USD | 3.4 BUSD | 2022 Q4 |
| 11/1/2022 | 1.16USD | 3.24 BUSD | 2022 Q3 |
EESG©
Eulerpool ESG Scorecard© for the Henry Schein stock
EEnvironment
20
Environment
SSocial
20
Social
GGovernance (Corporate Governance)
4
Governance (Corporate Governance)
The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.
Henry Schein Executives and Management Board
Mr. Stanley Bergman
(75)Chairman of the Board, Chief Executive Officer, Director · since 1980
Mr. Mark Mlotek
(69)Executive Vice President, Chief Strategic Officer · since 1994
Mr. Michael Ettinger
(64)Chief Operating Officer, Executive Vice President
Mr. Ronald South
(63)Chief Financial Officer, Senior Vice President
Mr. Philip Laskawy
(84)Lead Independent Director
Henry Schein Supply Chain
Frequently asked questions about Henry Schein
The business model of Henry Schein Inc revolves around being a leading provider of healthcare products and services. With a focus on the dental, veterinary, and medical industries, Henry Schein offers a wide range of products, equipment, and technology solutions to healthcare professionals worldwide. The company's business model emphasizes delivering value, quality, and innovation to its customers. Through strategic partnerships, efficient distribution channels, and a strong customer-centric approach, Henry Schein Inc aims to support healthcare providers in delivering optimal patient care while driving growth and profitability for the company.
Henry Schein stock
Henry Schein Peer Group
Henry Schein Ticker
Henry Schein FIGI
All fundamentals and in-depth analysis of Henry Schein
Our stock analysis for Henry Schein Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Henry Schein Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.